Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial ...

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far ...

Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce ...

Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind the strategy.

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.